BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24206941)

  • 1. Pleiotropic functions of antioxidant nanoparticles for longevity and medicine.
    Narayanan KB; Park HH
    Adv Colloid Interface Sci; 2013 Dec; 201-202():30-42. PubMed ID: 24206941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical nanomedicine.
    Rzigalinski BA; Meehan K; Davis RM; Xu Y; Miles WC; Cohen CA
    Nanomedicine (Lond); 2006 Dec; 1(4):399-412. PubMed ID: 17716143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold nanoparticles supported on nanoparticulate ceria as a powerful agent against intracellular oxidative stress.
    Menchón C; Martín R; Apostolova N; Victor VM; Alvaro M; Herance JR; García H
    Small; 2012 Jun; 8(12):1895-903. PubMed ID: 22454217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles: toxicity, radicals, electron transfer, and antioxidants.
    Kovacic P; Somanathan R
    Methods Mol Biol; 2013; 1028():15-35. PubMed ID: 23740111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain.
    Heckman KL; DeCoteau W; Estevez A; Reed KJ; Costanzo W; Sanford D; Leiter JC; Clauss J; Knapp K; Gomez C; Mullen P; Rathbun E; Prime K; Marini J; Patchefsky J; Patchefsky AS; Hailstone RK; Erlichman JS
    ACS Nano; 2013 Dec; 7(12):10582-96. PubMed ID: 24266731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.
    Ratnam DV; Ankola DD; Bhardwaj V; Sahana DK; Kumar MN
    J Control Release; 2006 Jul; 113(3):189-207. PubMed ID: 16790290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
    Babizhayev MA
    Cell Biochem Funct; 2011 Apr; 29(3):183-206. PubMed ID: 21381059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin: action as antioxidant and potential applications in human disease and aging.
    Bonnefont-Rousselot D; Collin F
    Toxicology; 2010 Nov; 278(1):55-67. PubMed ID: 20417677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological potential of cerium oxide nanoparticles.
    Celardo I; Pedersen JZ; Traversa E; Ghibelli L
    Nanoscale; 2011 Apr; 3(4):1411-20. PubMed ID: 21369578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydopamine Nanoparticles as Efficient Scavengers for Reactive Oxygen Species in Periodontal Disease.
    Bao X; Zhao J; Sun J; Hu M; Yang X
    ACS Nano; 2018 Sep; 12(9):8882-8892. PubMed ID: 30028940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in metal-induced oxidative stress and human disease.
    Jomova K; Valko M
    Toxicology; 2011 May; 283(2-3):65-87. PubMed ID: 21414382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neurodegenerative disorders with radical nanomedicine.
    Singh N; Cohen CA; Rzigalinski BA
    Ann N Y Acad Sci; 2007 Dec; 1122():219-30. PubMed ID: 18077575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative biomarkers to assess the nanoparticle-induced oxidative stress.
    Anreddy RN; Yellu NR; Devarakonda KR
    Methods Mol Biol; 2013; 1028():205-19. PubMed ID: 23740122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomedical applications of nano-antioxidant.
    Watal G; Watal A; Rai PK; Rai DK; Sharma G; Sharma B
    Methods Mol Biol; 2013; 1028():147-51. PubMed ID: 23740118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries.
    Yoshitomi T; Nagasaki Y
    Adv Healthc Mater; 2014 Aug; 3(8):1149-61. PubMed ID: 24482427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H2O2-triggered bubble generating antioxidant polymeric nanoparticles as ischemia/reperfusion targeted nanotheranostics.
    Kang C; Cho W; Park M; Kim J; Park S; Shin D; Song C; Lee D
    Biomaterials; 2016 Apr; 85():195-203. PubMed ID: 26874282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant nanoparticles for control of infectious disease.
    Elswaifi SF; Palmieri JR; Hockey KS; Rzigalinski BA
    Infect Disord Drug Targets; 2009 Aug; 9(4):445-52. PubMed ID: 19689385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of oxidative stress by p-hydroxybenzyl alcohol-containing biodegradable polyoxalate nanoparticulate antioxidant.
    Kim S; Park H; Song Y; Hong D; Kim O; Jo E; Khang G; Lee D
    Biomaterials; 2011 Apr; 32(11):3021-9. PubMed ID: 21292318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities.
    Eftekhari A; Dizaj SM; Chodari L; Sunar S; Hasanzadeh A; Ahmadian E; Hasanzadeh M
    Biomed Pharmacother; 2018 Jul; 103():1018-1027. PubMed ID: 29710659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.